Altimmune
ALT
112 hedge funds and large institutions have $79.2M invested in Altimmune in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 40 reducing their positions, and 23 closing their positions.
138% more call options, than puts
Call options by funds: $2.13M | Put options by funds: $898K
7% less funds holding
Funds holding: 120 → 112 (-8)
14.02% less ownership
Funds ownership: 71.55% → 57.53% (-14%)
30% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 23
33% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 40
36% less capital invested
Capital invested by funds: $125M → $79.2M (-$45.3M)
Top Buyers
| 1 |
Prudential Financial
Newark,
New Jersey
|
+$956K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$774K |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$712K |
| 4 |
D.E. Shaw & Co
New York
|
+$650K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$588K |
Top Sellers
| 1 |
LCM
Laurion Capital Management
New York
|
-$2.95M |
| 2 |
Millennium Management
New York
|
-$2.42M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$2.1M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.76M |
| 5 |
Morgan Stanley
New York
|
-$1.71M |
ALT Hedge Fund Activity: Q3 2023 in Review
112 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q3 2023, worth a combined $79.2M — down 36% from $125M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of ALT and 16 opened new positions — a net loss of 7 holders — while 40 trimmed existing stakes and 27 added.
The largest buyer was Prudential Financial, opening a new position worth an estimated $956K. The largest seller was Laurion Capital Management, cutting an estimated $2.95M.
- 112 institutional investors held Altimmune (ALT) as of Q3 2023, down from 120 in Q2 2023.
- Funds reported $79.2M of Altimmune stock for Q3 2023, down 36% quarter-over-quarter.
- 16 funds opened new Altimmune positions in Q3 2023 and 23 closed out, a net change of -7 holders.
- The largest Altimmune buyer in Q3 2023 was Prudential Financial, an estimated $956K added.
- The largest Altimmune seller in Q3 2023 was Laurion Capital Management, an estimated $2.95M sold.
Based on aggregated 13F filings for Q3 2023.